Charles S. Fuchs

113.2k total citations · 22 hit papers
721 papers, 58.8k citations indexed

About

Charles S. Fuchs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Charles S. Fuchs has authored 721 papers receiving a total of 58.8k indexed citations (citations by other indexed papers that have themselves been cited), including 421 papers in Oncology, 185 papers in Pulmonary and Respiratory Medicine and 159 papers in Pathology and Forensic Medicine. Recurrent topics in Charles S. Fuchs's work include Colorectal Cancer Treatments and Studies (160 papers), Gastric Cancer Management and Outcomes (138 papers) and Genetic factors in colorectal cancer (109 papers). Charles S. Fuchs is often cited by papers focused on Colorectal Cancer Treatments and Studies (160 papers), Gastric Cancer Management and Outcomes (138 papers) and Genetic factors in colorectal cancer (109 papers). Charles S. Fuchs collaborates with scholars based in United States, Japan and South Korea. Charles S. Fuchs's co-authors include Edward L. Giovannucci, Shuji Ogino, Andrew T. Chan, Jeffrey A. Meyerhardt, Walter C. Willett, Graham A. Colditz, Kana Wu, Katsuhiko Nosho, Gregory J. Kirkner and Robert J. Mayer and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Charles S. Fuchs

711 papers receiving 57.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

2013 1.9k citations Jonathan N. Glickman, Daniel C. Chung et al. profile →
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

2003 1.8k citations Richard M. Goldberg, Roscoe F. Morton et al. Journal of Clinical Oncology profile →
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

2013 1.1k citations Reiko Nishihara, Kana Wu et al. profile →
Postmenopausal Hormone Therapy and Mortality

1997 859 citations Charles S. Fuchs et al. profile →
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

2006 811 citations Edward L. Giovannucci, Charles S. Fuchs et al. profile →
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

1992 777 citations Charles S. Fuchs et al. profile →
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

2007 665 citations Charles S. Fuchs et al. Journal of Clinical Oncology profile →
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.

1997 651 citations Edward L. Giovannucci, Charles S. Fuchs et al. profile →
Physical Activity and Survival After Colorectal Cancer Diagnosis

2006 640 citations Jeffrey A. Meyerhardt, Edward L. Giovannucci et al. Journal of Clinical Oncology profile →
Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study

2003 626 citations Charles S. Fuchs et al. profile →
Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival

2012 602 citations Xiaoyun Liao, Paul Lochhead et al. profile →
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

2008 594 citations Shuji Ogino, Katsuhiko Nosho et al. profile →
A Prospective Study of Family History and the Risk of Colorectal Cancer

1994 590 citations Charles S. Fuchs et al. profile →
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2

2007 554 citations Andrew T. Chan, Shuji Ogino et al. profile →
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise

2016 541 citations Andrew X. Zhu, Charles S. Fuchs et al. The Oncologist profile →
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

2006 537 citations Jeffrey A. Meyerhardt, Charles S. Fuchs et al. Journal of Clinical Oncology profile →
A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis

2013 453 citations Ashwin N. Ananthakrishnan, Gauree G. Konijeti et al. profile →
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

2012 427 citations Mai Yamauchi, Teppei Morikawa et al. profile →
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease

2013 380 citations Ashwin N. Ananthakrishnan, Gauree G. Konijeti et al. profile →
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

2017 344 citations Matthew H. Kulke, Charles S. Fuchs et al. Journal of Clinical Oncology profile →
Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women

2018 337 citations Kana Wu, Kimmie Ng et al. profile →
Development and Validation of an Empirical Dietary Inflammatory Index

2016 323 citations Kana Wu, Charles S. Fuchs et al. profile →

Peers

Countries citing papers authored by Charles S. Fuchs

Since Specialization

Citations

This map shows the geographic impact of Charles S. Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Fuchs more than expected).

Fields of papers citing papers by Charles S. Fuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Fuchs. The network helps show where Charles S. Fuchs may publish in the future.

Co-authorship network of co-authors of Charles S. Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Fuchs. A scholar is included among the top collaborators of Charles S. Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Fuchs. Charles S. Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer 2023 ·Cancer Control ·Patrick W. McGarrah, Joleen M. Hubbard, Paul J. Novotny, Megan E. Branda, (unknown), Roscoe F. Morton, Charles S. Fuchs, Al B. Benson, Stephen K. Williamson, B. Findlay, Steven R. Alberts, Richard M. Goldberg, Jeff A. Sloan	3
2	Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial 2020 ·Cancer Prevention Research ·Justin C. Brown, Sui Zhang, Jennifer A. Ligibel, Melinda L. Irwin, Lee W. Jones, Nancy Campbell, Michaël Pollak, (unknown), Brenda Cartmel, Maura Harrigan, Sara M. Tolaney, Eric P. Winer, Kimmie Ng, Thomas A. Abrams, Tara Sanft, Pamela S. Douglas, Frank B. Hu, Charles S. Fuchs, Jeffrey A. Meyerhardt	31
3	A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer 2019 ·Clinical Cancer Research ·James J. Harding, Andrew X. Zhu, Todd M. Bauer, Toni K. Choueiri, Alexander Drilon, Martin H. Voss, Charles S. Fuchs, Ghassan K. Abou‐Alfa, Sameera R. Wijayawardana, Xuejing Aimee Wang, Brian A. Moser, (unknown), Volker Wacheck, Johanna C. Bendell	32
4	Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism 2018 ·Cancer Research ·Camila M. Lopes‐Ramos, Marieke L. Kuijjer, Shuji Ogino, Charles S. Fuchs, Dawn L. DeMeo, Kimberly Glass, John Quackenbush	63
5	Calcium Intake and Survival after Colorectal Cancer Diagnosis 2018 ·Clinical Cancer Research ·Wanshui Yang, Yanan Ma, (unknown), Mingyang Song, Kana Wu, Molin Wang, Andrew T. Chan, Shuji Ogino, Charles S. Fuchs, Vitaliy Poylin, Kimmie Ng, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Xuehong Zhang	32
6	Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma 2016 ·Clinical Cancer Research ·Kent W. Mouw, James M. Cleary, Brendan Reardon, (unknown), Lior Z. Braunstein, Jaegil Kim, Ali Amin‐Mansour, Diana Miao, (unknown), Joanna Chin, Patrick A. Ott, Charles S. Fuchs, Neil E. Martin, Gad Getz, Scott L. Carter, Harvey J. Mamon, Jason L. Hornick, Eliezer M. Van Allen, Alan D. D’Andrea	36
7	MicroRNA let-7 , T Cells, and Patient Survival in Colorectal Cancer 2016 ·Cancer Immunology Research ·Ruoxu Dou, Reiko Nishihara, Yin Cao, Tsuyoshi Hamada, Kosuke Mima, Atsuhiro Masuda, Yohei Masugi, Yan Shi, Mancang Gu, Wanwan Li, Annacarolina da Silva, Katsuhiko Nosho, Xuehong Zhang, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Zhi Rong Qian, Shuji Ogino	43
8	Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study 2016 ·Cancer Prevention Research ·Mingyang Song, Gauree G. Konijeti, Chen Yuan, Ashwin N. Ananthakrishnan, Shuji Ogino, Charles S. Fuchs, Edward L. Giovannucci, Kimmie Ng, Andrew T. Chan	32
9	Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer 2015 ·Clinical Cancer Research ·Nadine J. McCleary, Kaori Sato, Reiko Nishihara, Kentaro Inamura, Teppei Morikawa, Xuehong Zhang, Kana Wu, Mai Yamauchi, Sun A. Kim, Yasutaka Sukawa, Kosuke Mima, Zhi Rong Qian, Charles S. Fuchs, Shuji Ogino, Jeffrey A. Meyerhardt	11
10	Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women 2015 ·Cancer Prevention Research ·Mingyang Song, Raaj S. Mehta, Kana Wu, Charles S. Fuchs, Shuji Ogino, Edward L. Giovannucci, Andrew T. Chan	32
11	Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer 2013 ·The Oncologist ·Brian M. Wolpin, Kimmie Ng, Andrew X. Zhu, Thomas A. Abrams, Peter C. Enzinger, Nadine J. McCleary, Deborah Schrag, Eunice L. Kwak, Jill N. Allen, Pankaj Bhargava, Jennifer A. Chan, Wolfram Goessling, Lawrence S. Blaszkowsky, Jeffrey G. Supko, (unknown), Kaori Sato, Eileen Regan, Jeffrey A. Meyerhardt, Charles S. Fuchs	38
12	Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor 2013 ·Clinical Cancer Research ·Ian McCaffery, Yanyan Tudor, Hongjie Deng, Rui Tang, Samuel Suzuki, Sunita Badola, Hedy L. Kindler, Charles S. Fuchs, Elwyn Loh, Scott D. Patterson, Li Chen, Jennifer Gansert	54
13	Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study 2013 ·Clinical Cancer Research ·Andrew X. Zhu, Marek Ancukiewicz, Jeffrey G. Supko, Dushyant V. Sahani, Lawrence S. Blaszkowsky, Jeffrey A. Meyerhardt, Thomas A. Abrams, Nadine J. McCleary, Pankaj Bhargava, Alona Muzikansky, Susan Sheehan, Eileen Regan, (unknown), (unknown), Charles S. Fuchs, David P. Ryan, Rakesh K. Jain, Dan G. Duda	55
14	Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Mai Yamauchi, Paul Lochhead, Yu Imamura, Aya Kuchiba, Xiaoyun Liao, Zhi Rong Qian, Reiko Nishihara, Teppei Morikawa, Kaori Shima, Kana Wu, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs, Andrew T. Chan, Shuji Ogino	33
15	Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors 2012 ·Journal of Clinical Oncology ·Jennifer A. Chan, Keith Stuart, Craig C. Earle, Jeffrey W. Clark, Pankaj Bhargava, Rebecca A. Miksad, Lawrence S. Blaszkowsky, Peter C. Enzinger, Jeffrey A. Meyerhardt, Hui Zheng, Charles S. Fuchs, Matthew H. Kulke	207
16	Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers 2012 ·Clinical Cancer Research ·Yu Imamura, Teppei Morikawa, Xiaoyun Liao, Paul Lochhead, Aya Kuchiba, Mai Yamauchi, Zhi Rong Qian, Reiko Nishihara, Jeffrey A. Meyerhardt, Kevin M. Haigis, Charles S. Fuchs, Shuji Ogino	210
17	Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Andrew T. Chan, Yoshifumi Baba, Kaori Shima, Katsuhiko Nosho, Daniel C. Chung, Kenneth E. Hung, Umar Mahmood, (unknown), Kirtland Poss, (unknown), (unknown), Raju Kucherlapati, Charles S. Fuchs, Shuji Ogino	48
18	Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype 2009 ·Clinical Cancer Research ·Shuji Ogino, Katsuhiko Nosho, Natsumi Irahara, Jeffrey A. Meyerhardt, Yoshifumi Baba, Kaori Shima, Jonathan N. Glickman, Cristina R. Ferrone, Mari Mino–Kenudson, Noriko Tanaka, Glenn Dranoff, Edward L. Giovannucci, Charles S. Fuchs	308
19	A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases 2009 ·Clinical Cancer Research ·Shuji Ogino, Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Yoshifumi Baba, Saori Toyoda, Li Chen, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs	65
20	DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer 2009 ·Clinical Cancer Research ·Katsuhiko Nosho, Kaori Shima, Natsumi Irahara, Shoko Kure, Yoshifumi Baba, Gregory J. Kirkner, Li Chen, Sumita Gokhale, Aditi Hazra, Donna Spiegelman, Edward L. Giovannucci, Rudolf Jaenisch, Charles S. Fuchs, Shuji Ogino	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact